157 related articles for article (PubMed ID: 16388521)
1. Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells.
Alvero AB; O'Malley D; Brown D; Kelly G; Garg M; Chen W; Rutherford T; Mor G
Cancer; 2006 Feb; 106(3):599-608. PubMed ID: 16388521
[TBL] [Abstract][Full Text] [Related]
2. Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol.
Sapi E; Alvero AB; Chen W; O'Malley D; Hao XY; Dwipoyono B; Garg M; Kamsteeg M; Rutherford T; Mor G
Oncol Res; 2004; 14(11-12):567-78. PubMed ID: 15666998
[TBL] [Abstract][Full Text] [Related]
3. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells.
Herst PM; Petersen T; Jerram P; Baty J; Berridge MV
Biochem Pharmacol; 2007 Dec; 74(11):1587-95. PubMed ID: 17904534
[TBL] [Abstract][Full Text] [Related]
4. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
Kluger HM; McCarthy MM; Alvero AB; Sznol M; Ariyan S; Camp RL; Rimm DL; Mor G
J Transl Med; 2007 Jan; 5():6. PubMed ID: 17257402
[TBL] [Abstract][Full Text] [Related]
5. Phenoxodiol-Topotecan co-administration exhibit significant anti-tumor activity without major adverse side effects.
Alvero AB; Brown D; Montagna M; Matthews M; Mor G
Cancer Biol Ther; 2007 Apr; 6(4):612-7. PubMed ID: 17457041
[TBL] [Abstract][Full Text] [Related]
6. Phenoxodiol enhances the antitumor activity of gemcitabine in gallbladder cancer through suppressing Akt/mTOR pathway.
Li Y; Huang X; Huang Z; Feng J
Cell Biochem Biophys; 2014 Nov; 70(2):1337-42. PubMed ID: 24902539
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression.
Kurdow R; Schniewind B; Zoefelt S; Boenicke L; Boehle AS; Dohrmann P; Kalthoff H
Langenbecks Arch Surg; 2005 Jun; 390(3):243-8. PubMed ID: 15726400
[TBL] [Abstract][Full Text] [Related]
8. Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) induces apoptosis in ovarian cancer cells.
Alvero AB; Chen W; Sartorelli AC; Schwartz P; Rutherford T; Mor G
J Soc Gynecol Investig; 2006 Feb; 13(2):145-52. PubMed ID: 16443509
[TBL] [Abstract][Full Text] [Related]
9. Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells.
Kamsteeg M; Rutherford T; Sapi E; Hanczaruk B; Shahabi S; Flick M; Brown D; Mor G
Oncogene; 2003 May; 22(17):2611-20. PubMed ID: 12730675
[TBL] [Abstract][Full Text] [Related]
10. 7-(O)-Carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine: a novel compound capable of inducing cell death in epithelial ovarian cancer stem cells.
Green JM; Alvero AB; Kohen F; Mor G
Cancer Biol Ther; 2009 Sep; 8(18):1747-53. PubMed ID: 19738422
[TBL] [Abstract][Full Text] [Related]
11. Phenoxodiol, a novel approach for the treatment of ovarian cancer.
Mor G; Fu HH; Alvero AB
Curr Opin Investig Drugs; 2006 Jun; 7(6):542-8. PubMed ID: 16784025
[TBL] [Abstract][Full Text] [Related]
12. -(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro.
Macoska JA; Adsule S; Tantivejkul K; Wang S; Pienta KJ; Lee CT
Pharmacol Res; 2008; 58(5-6):323-31. PubMed ID: 18840529
[TBL] [Abstract][Full Text] [Related]
13. NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway.
Alvero AB; Montagna MK; Chen R; Kim KH; Kyungjin K; Visintin I; Fu HH; Brown D; Mor G
Cancer; 2009 Jul; 115(14):3204-16. PubMed ID: 19472400
[TBL] [Abstract][Full Text] [Related]
14. Noxa enhances the cytotoxic effect of gemcitabine in human ovarian cancer cells.
Cao K; Yang J; Lin C; Wang BN; Yang Y; Zhang J; Dai J; Li L; Nie CL; Yuan Z; Li MY
Cancer Biother Radiopharm; 2012 May; 27(4):259-66. PubMed ID: 22489660
[TBL] [Abstract][Full Text] [Related]
15. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1.
Aguero MF; Facchinetti MM; Sheleg Z; Senderowicz AM
Cancer Res; 2005 Apr; 65(8):3364-73. PubMed ID: 15833870
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells.
McPherson RA; Galettis PT; de Souza PL
Br J Cancer; 2009 Feb; 100(4):649-55. PubMed ID: 19209173
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers.
Kelly MG; Mor G; Husband A; O'Malley DM; Baker L; Azodi M; Schwartz PE; Rutherford TJ
Int J Gynecol Cancer; 2011 May; 21(4):633-9. PubMed ID: 21412168
[TBL] [Abstract][Full Text] [Related]
18. Involvement of BH3-only proapoptotic proteins in mitochondrial-dependent Phenoxodiol-induced apoptosis of human melanoma cells.
Yu F; Watts RN; Zhang XD; Borrow JM; Hersey P
Anticancer Drugs; 2006 Nov; 17(10):1151-61. PubMed ID: 17075314
[TBL] [Abstract][Full Text] [Related]
19. C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin.
Gao Z; Xu X; McClane B; Zeng Q; Litkouhi B; Welch WR; Berkowitz RS; Mok SC; Garner EI
Clin Cancer Res; 2011 Mar; 17(5):1065-74. PubMed ID: 21123456
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.
Kuroda T; Ogiwara H; Sasaki M; Takahashi K; Yoshida H; Kiyokawa T; Sudo K; Tamura K; Kato T; Okamoto A; Kohno T
Gynecol Oncol; 2019 Dec; 155(3):489-498. PubMed ID: 31604667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
